- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00552981
Effectiveness of Local Application of Warm Air in Patients With Common Cold (HELI Study) (HELI)
July 9, 2012 updated by: Claudia M. Witt, Charite University, Berlin, Germany
In a randomized controlled trial, the investigators include patients with beginning symptoms of a common cold and compare two interventions:
- the inhalation of warm air for inducing a warming of the throat and
- the inhalation of ambient air as control. As outcome the effect on symptoms and duration of the common cold will be assessed. The interventions will consist of visits with a duration of 2-3 minutes on three following days in a Finnish sauna. Patients will be fully dressed.
Study Overview
Status
Completed
Conditions
Study Type
Interventional
Enrollment (Actual)
157
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Berlin, Germany, 10117
- Institute for Social Medicine, Epidemiology, and Health Economics, Charité University Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 60 years (ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- symptom duration between 2 and 24 hours
- at least two of the ten following symptoms: cough, headache, hoarseness, muscle ache, nasal drainage, nasal congestion, scratchy throat, sore throat, sneezing, and fever
- no usage of medication bought in a pharmacy
- informed consent
Exclusion Criteria:
- fever >38.5°C
- systolic blood pressure below 100 mmHg or above 160 mmHg
- severe chronic disease, which makes study participation impossible
- pregnancy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
ACTIVE_COMPARATOR: 1
|
three times on three following days, each 2-3 minutes
|
SHAM_COMPARATOR: 2
|
three times on three following days, each 2-3 minutes
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Symptom Score for Common Cold
Time Frame: Area under the curve day 2 to 7
|
Area under the curve day 2 to 7
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Usage of medication against common cold
Time Frame: Day 1 to 7
|
Day 1 to 7
|
generalized feeling ill on a numeric rating scale 0-10,
Time Frame: Day 1, 2, 3, 5 and 7
|
Day 1, 2, 3, 5 and 7
|
safety (adverse events and serious adverse events)
Time Frame: 1 to 7 days
|
1 to 7 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2007
Primary Completion (ACTUAL)
April 1, 2009
Study Completion (ACTUAL)
April 1, 2009
Study Registration Dates
First Submitted
November 1, 2007
First Submitted That Met QC Criteria
November 1, 2007
First Posted (ESTIMATE)
November 2, 2007
Study Record Updates
Last Update Posted (ESTIMATE)
July 10, 2012
Last Update Submitted That Met QC Criteria
July 9, 2012
Last Verified
July 1, 2012
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- HELI-2007
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Common Cold
-
Cardiff UniversityCompletedCommon Cold/FluUnited Kingdom
-
Perrigo CompanyGlaxoSmithKline; Pfizer; McNeil Consumer Healthcare Division of McNEIL-PPC, Inc. and other collaboratorsCompletedNasal Congestion Associated With the Common ColdUnited States
-
NovartisCompletedCommon Cold Associated With CoughCanada
-
Probi ABCompletedAcute Upper Respiratory Tract Infections (Common Cold)Italy
-
Ache Laboratorios Farmaceuticos S.A.Suspended
-
Beijing Da-an Bio-technology Co., Ltd.Unknown
-
Brainfarma Industria Química e Farmacêutica S/ATechtrials Pesquisa e Tecnologia Ltda; PharmagenixUnknown
-
NovartisCompletedSore Throat Due to a Common ColdGermany
-
Boehringer IngelheimCompleted
-
Lund UniversityCoradil ABEnrolling by invitation
Clinical Trials on inhalation of warm air in a Finnish sauna
-
Air Liquide SATerminatedAnaesthesiaUnited Kingdom, France, Germany
-
Centre Hospitalier Universitaire, AmiensRecruitingSleep | Newborn | Chemical Pollutants ExposureFrance
-
I.M. Sechenov First Moscow State Medical UniversityEnrolling by invitationCOVID-19 | Quality of Life | Oxygen Consumption | Diastolic Dysfunction | Endothelial Function | Exercise ToleranceRussian Federation
-
University Hospital, Clermont-FerrandCompleted
-
University Hospital, Clermont-FerrandUnknown
-
Aljazeera HospitalCairo University; Kasr El Aini HospitalCompleted
-
University Hospital Hradec KraloveCompletedGeneral Anesthetic Drug Adverse ReactionCzech Republic
-
EpicentreHarvard Medical School (HMS and HSDM); Massachusetts General Hospital; Mbarara... and other collaboratorsCompleted
-
Central European Society for Anticancer Drug ResearchCompletedMetastatic Renal Cell CarcinomaGermany